1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, September 2016 (p3)

Pharmaceutical Analysis & Statistics in Oceania Countries, September 2016 (p3)

61-90 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Consumer Health in Australia

Consumer Health in Australia

  • $ 2423
  • Industry report
  • September 2016
  • by Euromonitor International

Consumer health in Australia recorded positive growth in 2016, albeit slower than that seen in 2015, which was driven by booming Chinese demand for Australian-made vitamins and dietary supplements. In ...

  • Industries : OTC
  • Countries : Australia
Swisse Wellness Pty Ltd in Consumer Health (Australia)

Swisse Wellness Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • September 2016
  • by Euromonitor International

The aim of Swisse Wellness is to grow its share in both Australia and overseas through the launch of on-trend and innovative products. The company plans to invest in science and research to support trust ...

  • Industries : OTC
  • Countries : China, Australia
Key Pharmaceuticals Pty Ltd in Consumer Health (Australia)

Key Pharmaceuticals Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • September 2016
  • by Euromonitor International

Key Pharmaceuticals’ strategy involves growing its share through the offer of safe, effective and high-quality products. The company prides itself on being Australian-owned and operated. It owns the ...

  • Industries : OTC
  • Countries : Australia
Nature’s Care Pty Ltd in Consumer Health (Australia)

Nature’s Care Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • September 2016
  • by Euromonitor International

The trade press reported in 2016 that Nature’s Care was up for sale, with the company appointing two investment banks to run a trade sale. The sale could fetch a price in the range of A$1 billion, with ...

  • Industries : OTC
  • Countries : Australia
Pharmacare Laboratories Pty Ltd in Consumer Health (Australia)

Pharmacare Laboratories Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • September 2016
  • by Euromonitor International

Pharmacare Laboratories is expected to focus on providing consumers with new and innovative products, with the company investing heavily in research and development. The company will consider Asian expansion ...

  • Industries : OTC
  • Countries : Australia
Blackmores Ltd in Consumer Health (Australia)

Blackmores Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • September 2016
  • by Euromonitor International

Blackmores continues to focus on four strategic priorities, with the company looking to improve its digital presence, drive further growth in Asia, improve its operational efficiency and be recognised ...

  • Industries : OTC
  • Countries : World, China, Australia, Asia
Online Pharmaceutical Sales in Australia - Industry Market Research Report

Online Pharmaceutical Sales in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • September 2016
  • by Ibisworld

A bitter pill: Strong competition and regulatory hurdles constrain industry growth Abstract Online Pharmaceutical Sales in Australia Industry companies primarily sell pharmaceutical products via the internet. ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

  • $ 1995
  • Industry report
  • September 2016
  • by Global Data

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory ...

  • Industries : Healthcare, Medical Device, Pharmaceutical
  • Countries : Australia, Oceania
Vitamin and Supplement Stores in Australia - Industry Market Research Report

Vitamin and Supplement Stores in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • August 2016
  • by Ibisworld

Bitter pill: Strong external competition is reducing industry revenue despite higher demand Abstract Vitamin and Supplement Stores in Australia This industry includes bricks-and-mortar stores that primarily ...

  • Industries : OTC
  • Countries : Australia
New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary New Zealand Pharmaceuticals Ltd. (NZP), a subsidiary of Archer Capital is a contract manufacturing company that manufactures biochemicals and natural extracts for health, cosmetic, biotechnology, ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report

Pharmaceuticals Wholesaling in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • August 2016
  • by Ibisworld

On the mend: Higher volumes and production diversification will help underpin growth Abstract Pharmaceuticals Wholesaling in Australia The industry is made up of companies that wholesale pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceuticals Packing and Labelling Services in Australia - Industry Market Research Report

Pharmaceuticals Packing and Labelling Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • August 2016
  • by Ibisworld

Leader of the pack: Technological improvements are set to boost industry revenue Abstract Pharmaceuticals Packing and Labelling Services in Australia Industry operators provide packaging and labelling ...

  • Industries : Packaging
  • Countries : Australia
Chemical and Pharmaceutical Plants Construction in New Zealand to 2019: Market Databook

Chemical and Pharmaceutical Plants Construction in New Zealand to 2019: Market Databook

  • $ 500
  • Industry report
  • August 2016
  • by Timetric

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in New Zealand to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Chemical and Pharmaceutical Plants Construction in Australia to 2020: Market Databook

Chemical and Pharmaceutical Plants Construction in Australia to 2020: Market Databook

  • $ 500
  • Industry report
  • August 2016
  • by Timetric

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in Australia to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : Australia
IMS Country Review 2016: Australia

IMS Country Review 2016: Australia

  • $ 3670
  • Industry report
  • July 2016
  • by IMS Health

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms ...

  • Industries : Therapy
  • Countries : United States, Australia
Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2016

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : OTC, Pharmaceutical, Therapy
  • Countries : United States, World, New Caledonia
Circadian Technologies Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Circadian Technologies Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : Australia, United States, United Kingdom
Aspen Pharmacare Holdings Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Aspen Pharmacare Holdings Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : World, Australia, South Africa, Africa
TFS Corporation Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

TFS Corporation Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : United States, Australia, United Kingdom
Derma Sciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Derma Sciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : United States, New Zealand, United Kingdom
Mesoblast Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Mesoblast Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Countries : United Kingdom, Australia, United States
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia

  • $ 1700
  • Industry report
  • June 2016
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Pharmaceutical
  • Countries : Australia
Phosphagenics Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Phosphagenics Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical
  • Countries : Australia, United Kingdom
Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016

Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016

  • $ 3500
  • Industry report
  • June 2016
  • by Global Markets Direct

Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : World, United States, China, Australia
Alternative Health Therapies in Australia - Industry Market Research Report

Alternative Health Therapies in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • May 2016
  • by Ibisworld

A natural success: Growing public acceptance of industry services boosts revenue Abstract Alternative Health Therapies in Australia Industry practitioners primarily deliver treatments that are not commonly ...

  • Industries : Alternative Medicine
  • Countries : Australia
Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016

Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016

  • $ 3500
  • Industry report
  • May 2016
  • by Global Markets Direct

Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline ...

  • Industries : Cancer, Pathology, Pharmaceutical, Therapy
  • Countries : World, United States, Australia
Fertility Clinics in Australia - Industry Market Research Report

Fertility Clinics in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • May 2016
  • by Ibisworld

Fertile ground: Technological advances have increased industry success rates, boosting demand Abstract Fertility Clinics in Australia Medical facilities in this industry offer treatments to aid individuals ...

  • Industries : Medical Facility
  • Countries : Australia
Fertility Clinics in Australia - Industry Market Research Report

Fertility Clinics in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • May 2016
  • by Ibisworld

Fertile ground: Technological advances have increased industry success rates, boosting demand Abstract Fertility Clinics in Australia Medical facilities in this industry offer treatments to aid individuals ...

  • Industries : Medical Facility
  • Countries : Australia
2016-2020 Australia Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emergin

2016-2020 Australia Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emergin

  • $ 2450
  • Industry report
  • May 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Australia
Progen Pharmaceuticals Limited (PGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Progen Pharmaceuticals Limited (PGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2016
  • by Global Data

Summary Progen Pharmaceuticals Limited (Progen Pharmaceuticals), formerly Progen Industries Ltd, is a biotechnology company that researches, develops, and manufactures small molecule-based cancer therapeutics. ...

  • Industries : Pharmaceutical
  • Countries : Australia

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.